Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models.
Lim JL, Jensen SM, Plomp JJ, Vankerckhoven B, Kneip C, Coppejans R, Steyaert C, Moens K, De Clercq L, Tannemaat MR, Ulrichts P, Silence K, van der Maarel SM, Vergoossen DLE, Vanhauwaert R, Verschuuren JJ, Huijbers MG.
Lim JL, et al. Among authors: jensen sm.
iScience. 2024 Dec 21;28(2):111684. doi: 10.1016/j.isci.2024.111684. eCollection 2025 Feb 21.
iScience. 2024.
PMID: 39898046
Free PMC article.